Catalyst Wire Dossier Catalyst Wire Dossier

ARGX-117

· argenx
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARGX-117, covering 2024-10-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function [Phase 2]

See pricing